Infections during induction therapy of childhood acute lymphoblastic leukemia - No association to mannose-binding lectin deficiency

European Journal of Haematology

Volumn 76, Issue 6, 2006, Pages 481-487

  Lausen, Birgitte ^a   Schmiegelow, Kjeld ^a   Andreassen, Bente ^a   Madsen, Hans O ^a   Garred, Peter ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Acute lymphoblastic leukemia; Children; Infection; Mannose binding lectin

Indexed keywords

C REACTIVE PROTEIN; COTRIMOXAZOLE; DOXORUBICIN; MANNOSE BINDING LECTIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIMICROBIAL THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEVER; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; INFECTION COMPLICATION; INFECTION RISK; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MBL GENE; MBL2 GENE; MORBIDITY; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK ASSESSMENT;

ADOLESCENT; AGE FACTORS; ALLOPURINOL; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTEREMIA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE SUSCEPTIBILITY; DOXORUBICIN; FEMALE; FEVER; FUNGEMIA; GENOTYPE; HUMANS; IMMUNITY, NATURAL; IMMUNOCOMPROMISED HOST; INCIDENCE; INFANT; INFECTION; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; MANNOSE-BINDING LECTIN; NEUTROPENIA; PREDNISOLONE; PROMOTER REGIONS (GENETICS); REMISSION INDUCTION; VINCRISTINE;

EID: 33646507271     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00632.x     Document Type: Article

References (32)

1. J ones G K onsler G P usek S Infection risk factors in febrile, neutropenic children and adolescents Pediatric Hematol Oncol 1996 13 217 229
2. C hristiansen MS H eyman M M öttönen M Z eller B J onmundsson G H asle H Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. Br J Haematol 2005 131 50 58
3. R ahiala J P erkkiö M R iikonen P Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients Pediatric Hematol Oncol 1997 15 165 174
4. W ehl G A llerberger F H eitger A M eister B M aurer K F ink F-M Trends in infection morbidity in a pediatric oncology ward, 1986-1995 Med Pediatr Oncol 1999 32 336 343
5. H argrave D H ann I R ichards S et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI) Br J Haematol 2001 112 293 299
6. T urner MW Mannose-binding lectin: The pluripotent molecule of the innate immune system Immunol Today 1996 17 532 540
7. T hiel S V orup -J ensen T S tover C et al. A second serine protease associated with mannan-binding lectin that activates complement Nature 1997 386 506 510
8. G arred P M adsen HO H ofmann B S vejgaard A Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency The Lancet 1995 346 941 943
9. S ummerfield JA R yder S S umiya M et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults The Lancet 1995 345 886 889
10. G arred P M adsen HO B alslev U et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin The Lancet 1997 349 236 240
11. S ummerfield JA S umiya M L evin M T urner MW Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series BMJ 1997 314 1229
12. S astry K H erman G D ay L D eignan E B runs G M orton C. The human mannose-binding protein gene J Exp Med 1989 170 1175 1189
13. T aylor M B rickell P C raig R S ummerfield JA Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein Biochem J 1989 262 763 771
14. M adsen HO G arred P K urtzhals JAL et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein Immunogenetics 1994 40 37 44
15. M adsen HO G arred P T hiel S et al. Interplay between promotor and structural gene variants control basal serum level of mannan-binding protein J Immunol 1995 155 3013 3020
16. M adsen HO V idem V S vejgaard A S vennevig J G arred P Association of mannose-binding-lectin deficiency with severe atherosclerosis The Lancet 1998 352 959 960
17. N eth O H ann I T urner MW K lein NJ Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study Lancet 2001 358 614 618
18. P eterslund NA K och C J ensenius JC T hiel S Association between deficiency of mannose-binding lectin and severe infections after chemotherapy Lancet 2001 358 637 638
19. H oriuchi T G ondo H M iyagawa H et al. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT Genes Immun 2005 6 162 166
20. K ilpatrick DC M c L intock LA A llan EK et al. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections Clin Exp Immunol 2003 134 279 284
21. B ergmann OJ C hristiansen M L aursen I et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy Eur J Haematol 2003 70 91 97
22. S chmiegelow K G arred P L ausen B A ndreassen B P etersen BL M adsen HO Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia Blood 2002 100 3757 3760
23. G ustafsson G S chmiegelow K F orestier E et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation Leukemia 2000 14 2267 2275
24. S chroder H A gger K R osthøj S C arlsen N S chmiegelow K Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia Dan Med Bull 2001 48 275 277
25. S chmiegelow K P ulczynska M Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts Am J Pediatr Hematol Oncol 1990 12 462 467
26. G arred P M adsen HO S vejgaard A Genetics of human mannan-binding protein In E zekowitz RA S astry K R eid K eds Collectins and Innate Immunity Austin, TX RG Landers Company 1996 139 164
27. G arred P P ressler T M adsen HO et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis J Clin Invest 1999 104 431 437
28. K och A M elbye M S orensen P et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood JAMA 2001 285 1316 1321
29. S hi L T akahashi K D undee J et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus J Exp Med 2004 199 1379 1390
30. V aldimarsson H S tefansson M V ikingsdottir T et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans Scand J Immunol 1998 48 116 123
31. G arred P P ressler T L anng S et al. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease Pediatr Pulmonol 2002 33 201 207
32. V aldimarsson H V ikingsdottir T B ang P et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study Scand J Immunol 2004 59 97 102